{"id":"https://openalex.org/W2915523134","doi":"https://doi.org/10.1007/s40265-019-01067-3","title":"Eravacycline: A Review in Complicated Intra-Abdominal Infections","display_name":"Eravacycline: A Review in Complicated Intra-Abdominal Infections","alternate_titles":[],"publication_year":2019,"publication_date":"2019-02-01","ids":{"openalex":"https://openalex.org/W2915523134","doi":"https://doi.org/10.1007/s40265-019-01067-3","mag":"2915523134","pmid":"https://pubmed.ncbi.nlm.nih.gov/30783960","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6505493"},"language":"en","primary_location":{"id":"doi:10.1007/s40265-019-01067-3","doi":"https://doi.org/10.1007/s40265-019-01067-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40265-019-01067-3","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40265-019-01067-3.pdf","source":{"id":"https://openalex.org/S4436492","display_name":"Drugs","issn_l":"0012-6667","issn":["0012-6667","1179-1950"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2915523134"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s40265-019-01067-3.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109531112","display_name":"Lesley J. Scott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115663","display_name":"Springer Nature (New Zealand)","ror":"https://ror.org/029zamy29","country_code":"NZ","type":"company","lineage":["https://openalex.org/I1313014049","https://openalex.org/I4210112888","https://openalex.org/I4210115663"]}],"countries":["NZ"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Lesley J. Scott","raw_affiliation_strings":["Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. demail@springer.com","Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. demail@springer.com","institution_ids":["https://openalex.org/I4210115663"]},{"raw_affiliation_string":"Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand","institution_ids":["https://openalex.org/I4210115663"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5109531112"],"corresponding_institution_ids":["https://openalex.org/I4210115663"],"apc_list":{"value":3760,"currency":"USD","value_usd":3760},"apc_paid":{"value":3760,"currency":"USD","value_usd":3760},"fwci":0.8117,"has_fulltext":true,"cited_by_count":131,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.63532764,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"79","issue":"3","first_page":"315","last_page":"324"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.4487000107765198,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.4487000107765198,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.4357999861240387,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.0689999982714653,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eravacycline","display_name":"eravacycline","score":1.0},{"id":"https://openalex.org/keywords/complicated-intra-abdominal-infections","display_name":"complicated intra-abdominal infections","score":0.968999981880188},{"id":"https://openalex.org/keywords/tetracycline-resistance","display_name":"tetracycline resistance","score":0.925000011920929},{"id":"https://openalex.org/keywords/anaerobic-bacteria","display_name":"anaerobic bacteria","score":0.7139999866485596},{"id":"https://openalex.org/keywords/gram-positive-bacteria","display_name":"Gram-positive bacteria","score":0.7590000033378601},{"id":"https://openalex.org/keywords/gram-negative-bacteria","display_name":"Gram-negative bacteria","score":0.8090000152587891},{"id":"https://openalex.org/keywords/ertapenem","display_name":"ertapenem","score":0.8859999775886536},{"id":"https://openalex.org/keywords/meropenem","display_name":"meropenem","score":0.9980000257492065},{"id":"https://openalex.org/keywords/empirical-antibiotic-therapy","display_name":"empirical antibiotic therapy","score":0.6790000200271606},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.6869999766349792},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.6200000047683716},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.6309999823570251}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8585284948348999},{"id":"https://openalex.org/C2777027569","wikidata":"https://www.wikidata.org/wiki/Q420595","display_name":"Tigecycline","level":3,"score":0.8114809989929199},{"id":"https://openalex.org/C2778368673","wikidata":"https://www.wikidata.org/wiki/Q553220","display_name":"Ertapenem","level":5,"score":0.7995634078979492},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7725836038589478},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4216667115688324},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.4186203181743622},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4183875322341919},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.4111515283584595},{"id":"https://openalex.org/C2779375183","wikidata":"https://www.wikidata.org/wiki/Q421670","display_name":"Meropenem","level":4,"score":0.3831847608089447},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.36066165566444397},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35354045033454895},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.33173996210098267},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.3197462856769562},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28357231616973877},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.1825064718723297},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07308101654052734},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077727","descriptor_name":"Ertapenem","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000077731","descriptor_name":"Meropenem","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000078304","descriptor_name":"Tigecycline","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013754","descriptor_name":"Tetracyclines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013754","descriptor_name":"Tetracyclines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024901","descriptor_name":"Drug Resistance, Multiple, Bacterial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059413","descriptor_name":"Intraabdominal Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1007/s40265-019-01067-3","doi":"https://doi.org/10.1007/s40265-019-01067-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40265-019-01067-3","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40265-019-01067-3.pdf","source":{"id":"https://openalex.org/S4436492","display_name":"Drugs","issn_l":"0012-6667","issn":["0012-6667","1179-1950"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5504563","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6505493","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6505493","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6505493/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"Text"},{"id":"pmid:30783960","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30783960","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s40265-019-01067-3","doi":"https://doi.org/10.1007/s40265-019-01067-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40265-019-01067-3","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40265-019-01067-3.pdf","source":{"id":"https://openalex.org/S4436492","display_name":"Drugs","issn_l":"0012-6667","issn":["0012-6667","1179-1950"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2915523134.pdf","grobid_xml":"https://content.openalex.org/works/W2915523134.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1874122563","https://openalex.org/W1985065307","https://openalex.org/W2020591349","https://openalex.org/W2077730723","https://openalex.org/W2088945335","https://openalex.org/W2089919229","https://openalex.org/W2133406641","https://openalex.org/W2156918227","https://openalex.org/W2163177484","https://openalex.org/W2172196696","https://openalex.org/W2266943560","https://openalex.org/W2339307736","https://openalex.org/W2406699864","https://openalex.org/W2461641769","https://openalex.org/W2473138844","https://openalex.org/W2517828327","https://openalex.org/W2550643720","https://openalex.org/W2565978645","https://openalex.org/W2580013489","https://openalex.org/W2583549666","https://openalex.org/W2606224033","https://openalex.org/W2729161724","https://openalex.org/W2735724836","https://openalex.org/W2751939257","https://openalex.org/W2758903011","https://openalex.org/W2777879918","https://openalex.org/W2783102466","https://openalex.org/W2790135539","https://openalex.org/W2888520542","https://openalex.org/W2896477081","https://openalex.org/W2897091677","https://openalex.org/W2904230285"],"related_works":["https://openalex.org/W2999230956","https://openalex.org/W2962248781","https://openalex.org/W2981140471","https://openalex.org/W2977481237","https://openalex.org/W2945926743","https://openalex.org/W2550643720","https://openalex.org/W2891943463","https://openalex.org/W2156918227","https://openalex.org/W4238022579","https://openalex.org/W3213646299"],"abstract_inverted_index":{"Eravacycline":[0,115],"(Xerava\u2122),":[1],"a":[2,48,181],"novel":[3,182],"fully":[4],"synthetic":[5],"fluorocycline,":[6],"consists":[7],"of":[8,51,71,107,136,139,148,188,199],"the":[9,17,69,102,129,186],"tetracyclic":[10,18],"core":[11],"scaffold":[12],"with":[13,121,191],"unique":[14],"modifications":[15],"in":[16,25,65,76,85,105,111,170],"D":[19],"ring;":[20],"consequently,":[21],"it":[22],"exhibits":[23,44],"potent":[24,45,169],"vitro":[26,171],"activity":[27,46,149,172],"against":[28,47,150],"Gram-positive":[29,54],"and":[30,55,58,127,160,166,173],"-negative":[31,56],"bacterial":[32],"strains":[33],"expressing":[34,157],"certain":[35,158],"common":[36,151],"tetracycline-specific":[37],"acquired":[38,163],"resistance":[39,164],"mechanisms.":[40],"In":[41,79],"vitro,":[42],"eravacycline":[43,62,89,179],"broad":[49,146],"spectrum":[50,147],"clinically":[52,152],"relevant":[53,153],"aerobic":[57],"anaerobic":[59],"bacteria.":[60],"Intravenous":[61],"is":[63,202],"approved":[64],"several":[66],"countries":[67],"for":[68,185],"treatment":[70,187],"complicated":[72],"intra-abdominal":[73],"infections":[74],"(cIAIs)":[75],"adult":[77,189],"patients.":[78],"two":[80],"pivotal":[81],"double-blind,":[82],"multinational":[83],"trials":[84],"this":[86],"patient":[87],"population,":[88],"(infusion":[90],"\u2248":[91],"1":[92],"h)":[93],"was":[94],"noninferior":[95],"to":[96,141],"intravenous":[97],"ertapenem":[98],"or":[99],"meropenem":[100],"at":[101],"test-of-cure":[103],"visit":[104],"terms":[106],"clinical":[108],"response":[109],"rates":[110],"all":[112],"prespecified":[113],"populations.":[114],"had":[116],"an":[117],"acceptable":[118],"tolerability":[119,175],"profile,":[120],"infusion":[122],"site":[123],"reactions,":[124,134],"nausea,":[125],"vomiting":[126],"diarrhoea":[128],"most":[130,135],"commonly":[131],"reported":[132],"adverse":[133],"which":[137],"were":[138],"mild":[140],"moderate":[142],"severity.":[143],"Given":[144],"its":[145,167],"pathogens":[154,201],"(including":[155],"those":[156],"tetracycline-":[159],"other":[161],"antibacterial-specific":[162],"mechanisms)":[165],"more":[168],"better":[174],"profile":[176],"than":[177],"tigecycline,":[178],"provides":[180],"emerging":[183],"option":[184],"patients":[190],"cIAIs,":[192],"especially":[193],"as":[194],"empirical":[195],"therapy":[196],"when":[197],"coverage":[198],"resistant":[200],"required.":[203]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2915523134","counts_by_year":[{"year":2026,"cited_by_count":25},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":24},{"year":2023,"cited_by_count":20},{"year":2022,"cited_by_count":15},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2019-03-02T00:00:00"}
